Article Versions Notes

Gorina DS, Lastovka AV, Rogachev AD, Podturkina AV, Pavlova AV, Ardashov OV, Li-Zhulanov NS, Tolstikova TG, Volcho KP, Salakhutdinov NF. Pharmacokinetics and Dose Proportionality Study of a Novel Antiparkinsonian Agent, a 1H-1,2,4-Triazol-3-ylthio-conjugate of Prottremine. Molecules. 2024; 29(18):4498. https://doi.org/10.3390/molecules29184498

Gorina, Daria S., Anastasiya V. Lastovka, Artem D. Rogachev, Alexandra V. Podturkina, Alla V. Pavlova, Oleg V. Ardashov, Nikolai S. Li-Zhulanov, Tatyana G. Tolstikova, Konstantin P. Volcho, and Nariman F. Salakhutdinov. 2024. "Pharmacokinetics and Dose Proportionality Study of a Novel Antiparkinsonian Agent, a 1H-1,2,4-Triazol-3-ylthio-conjugate of Prottremine" Molecules 29, no. 18: 4498. https://doi.org/10.3390/molecules29184498

Gorina, D. S., Lastovka, A. V., Rogachev, A. D., Podturkina, A. V., Pavlova, A. V., Ardashov, O. V., Li-Zhulanov, N. S., Tolstikova, T. G., Volcho, K. P., & Salakhutdinov, N. F. (2024). Pharmacokinetics and Dose Proportionality Study of a Novel Antiparkinsonian Agent, a 1H-1,2,4-Triazol-3-ylthio-conjugate of Prottremine. Molecules, 29(18), 4498. https://doi.org/10.3390/molecules29184498